Guo Yuan want Li Cheng to go to Longcheng Biology for two reasons.
There are too many connections between First Longcheng Biology and him. Lin Yumo and Su Yurou still have 02 in their phones. Li Cheng might connect something to Longcheng Biology.
Secondly, this was Guo Yuan's own business, Guo Yuan want Lin Yumo to encounter any unknown dangers because of him.
Speaking of Longcheng Biology, Lin Yumo is currently preparing for a trip to Vietnam to conduct research.
However, Su Yurou had just gone to South Korea, Lin Yumo wanted to at least wait for Su Yurou to come back from South Korea before going there herself.
Su Yurou went to South Korea to hire a professional plastic surgeon there.
The medical aesthetic institution under Longcheng Biology has been downgraded due to a lack of professional doctors and is now basically at a standstill.
The first step to saving this cosmetic surgery clinic is definitely to hire a professional doctor.
Although Lin Yumo disliked the medical aesthetics institution, Su Yurou and the shareholders unanimously decided to revitalize it, so Lin Yumo couldn't insist on selling it on her own.
So we had no choice but to let Su Yurou do it.
As for the matter of establishing a branch in Vietnam, the senior management of Longcheng Biology simply regarded it as a normal business activity.
As Lin Yumo said, the purpose of establishing a branch in Vietnam this time is to develop a highly effective Foot-and-Mouth Disease vaccine.
Currently, Longcheng Biology's biggest source of income is undoubtedly the Swine Fever Vaccine, but there are indeed many inconveniences in doing import and export business of Swine Fever Vaccine in China.
Even without Lin Yumo saying it, the senior management of Longcheng Biology had already considered establishing branches overseas to facilitate the import and export of vaccines.
However, the senior management of Longcheng Biology had not yet decided where to establish a branch office.
Now Lin Yumo suddenly says she wants to establish a branch in Vietnam to conduct experiments on a highly effective Foot-and-Mouth Disease vaccine.
For the other senior executives of Longcheng Biology, this was equivalent to deciding the country for establishing a branch company, although some of them found it strange that Lin Yumo chose Vietnam as the location for the branch company.
But since Lin Yumo has made her decision, and the company also has similar ideas, we might as well just go along with Lin Yumo's idea.
Therefore, during this period, Lin Yumo sent company personnel to Vietnam in batches on multiple occasions for inspection.
Three locations were ultimately selected. As for where to finally establish a branch office, Lin Yumo would have to personally visit and investigate before making a decision.
Vietnam also warmly welcomed Longcheng Biology's arrival.
Vietnam today is very similar to China decades ago: a young population, basic compulsory education, many ports close to major global shipping routes, and a generally secure environment. It will inevitably strive to leverage its labor cost advantage to attract excellent foreign companies.
Longcheng Biology holds Swine Fever Vaccine and also has many other drug patents in the pharmaceutical field. Currently, Vietnam attracts mostly manufacturing companies.
There are very few pharmaceutical companies like Longcheng Biology.
Therefore, they showed considerable sincerity towards Longcheng Biology's entry, offering money, land, and various preferential policies.
"General Manager Lin, I've contacted all the medical equipment companies you asked me to, and they've all said they can provide us with medical equipment as usual," said Bai Yuzhen, Lin Yumo's assistant, as she walked in.
"What is their quote?" Lin Yumo asked.
"The whole package will cost more than 21 million."
"So expensive?"
"Those companies all say that production costs have increased recently, and equipment costs have increased accordingly."
Lin Yumo snorted coldly upon hearing this. "What do you mean by increased production costs? You just want to raise prices!"
China's medical equipment lags behind that of foreign countries. If you want to buy the most advanced medical equipment, you have to go abroad.
These companies, relying on their patented technology, often raise prices arbitrarily and rip off customers.
Speaking of medical devices, Lin Yumo couldn't help but recall a time before she returned to China. A young man whose family was in the medical device business deliberately approached her after learning that she was the daughter of the chairman of Longcheng Biology. He wanted to develop a romantic relationship with her and then use that relationship to help Longcheng Biology enter the medical device industry.
After seeing through his intentions, Lin Yumo directly rejected him and then asked her father about the situation of the domestic medical device industry.
It was for this reason that Lin Yumo gained some understanding of the medical device industry.
In short, our medical device industry has been in a period of growth, but it still lags behind developed countries in terms of technological content and other aspects. In particular, with key technologies being monopolized, the quality and level of medical devices in my country have always been unable to compare with those in developed countries.
According to Lin Yumo's understanding, the shortcomings in the development of the medical device industry in China mainly lie in four aspects:
First, medical device companies lack sufficient strength. Medical devices belong to the high-tech industry, so a large amount of capital needs to be invested in the product development process.
However, currently, more than 92% of companies invest no more than 2% of their sales revenue in research and development, and only a very small number can reach 3%.
Furthermore, the number of professional researchers is relatively small, which gives you an idea of how dire the current situation is for medical devices.
Secondly, our medical device technology is limited. From a technical perspective, our medical device products are unlikely to reach the level of foreign products.
In my country, less than 10% of medical devices can reach the world's advanced level, and the return rate of domestic devices is much higher than that of similar foreign products. It is no exaggeration to say that the quality problems of medical devices caused by the lack of technology are the primary problem that the medical device industry needs to solve at present.
Third, the trade deficit in medical devices is too large. Currently, the majority of our medical device exports are relatively common surgical instruments.
The imported medical equipment is mostly expensive and consists of high-tech products. Ultimately, the problem stems from the aforementioned issue: insufficient technological capabilities.
Fourth, there is a lack of well-known brands. Currently, our medical device industry has not yet established a well-known brand.
On the one hand, this is due to technological limitations or product quality; on the other hand, media and public opinion are controlled, preventing our companies from effectively promoting their products.
These issues are all out in the open; anyone in the industry would know them.
These are all things that urgently need to be changed, because with the continuous development of the economy and society, people have more and more channels to access information.
Patients have also come to understand the importance of medical devices in treating diseases, and many patients will consider the configuration of medical devices as a key factor when choosing a medical institution.
Therefore, hospitals will gradually increase their purchases of medical equipment. At that time, these medical devices cannot all be imported, right?
Therefore, both the government and the pharmaceutical industry itself are encouraging various new technology companies to enter the medical device industry.